{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:18:56Z","timestamp":1789759136494,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A novel <jats:italic>LMNA<\/jats:italic> p.(Glu105Leu) variant was identified in five families with dilated cardiomyopathy (DCM), revealed as a local founder variant originating approximately 650 years ago. Genetic testing and clinical analysis of 795 DCM patients demonstrated that probands with this variant typically present with severe DCM in their sixties, characterized by high prevalence of late gadolinium enhancement, arrhythmias, and conduction disorders. Time-to-event analysis suggested a later onset of clinical symptoms compared to other <jats:italic>LMNA<\/jats:italic> variants, with a trend towards longer event-free survival. Microscopic imaging of patient fibroblasts, induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs), and heart tissue confirmed structural nuclear <jats:italic>LMNA<\/jats:italic>-associated abnormalities. Patient iPSC-CMs exhibited distinct sarcomeric disorganization, increased glucose uptake and glycogen content, reduced mitochondrial function and biogenesis, and delayed contractile function. These findings support the pathogenicity of the variant and demonstrate its profound impact on structural and metabolic functions in cardiomyocytes. <\/jats:p>","DOI":"10.1038\/s41598-025-08495-0","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T01:02:10Z","timestamp":1751590930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical and metabolic consequences of a historic pathogenic lamin A\/C founder variant"],"prefix":"10.1038","volume":"15","author":[{"given":"L. Y.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Torfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J. V.","family":"Vanherle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. R. F.","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L. V. M.","family":"Stroeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M. A.","family":"Willemars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Schianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kapsokalyvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Weltjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Swinnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Strzelecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. P. C.","family":"Krapels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R. B.","family":"Heymans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Glatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"van den Wijngaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. G.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Broers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F. P.","family":"Luiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Hoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A. J.","family":"Verdonschot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nabben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"8495_CR1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","volume":"402","author":"S Heymans","year":"2023","unstructured":"Heymans, S., Lakdawala, N. K., Tsch\u00f6pe, C. & Klingel, K. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet 402, 998\u20131011. https:\/\/doi.org\/10.1016\/S0140-6736(23)01241-2 (2023).","journal-title":"Lancet"},{"key":"8495_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","volume":"390","author":"RG Weintraub","year":"2017","unstructured":"Weintraub, R. G., Semsarian, C. & Macdonald, P. Dilated cardiomyopathy. Lancet 390, 400\u2013414. https:\/\/doi.org\/10.1016\/S0140-6736(16)31713-5 (2017).","journal-title":"Lancet"},{"key":"8495_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","volume":"121","author":"EM McNally","year":"2017","unstructured":"McNally, E. M. & Mestroni, L. Dilated cardiomyopathy. Circul. Res. 121, 731\u2013748. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309396 (2017).","journal-title":"Circul. Res."},{"key":"8495_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/circulationaha.120.053033","volume":"144","author":"E Jordan","year":"2021","unstructured":"Jordan, E. et al. Evidence-based assessment of genes in dilated cardiomyopathy. Circulation 144, 7\u201319. https:\/\/doi.org\/10.1161\/circulationaha.120.053033 (2021).","journal-title":"Circulation"},{"key":"8495_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/circgen.120.003031","volume":"13","author":"JAJ Verdonschot","year":"2020","unstructured":"Verdonschot, J. A. J. et al. Implications of genetic testing in dilated cardiomyopathy. Circ. Genom Precis Med. 13, 476\u2013487. https:\/\/doi.org\/10.1161\/circgen.120.003031 (2020).","journal-title":"Circ. Genom Precis Med."},{"key":"8495_CR6","doi-asserted-by":"publisher","first-page":"e005220","DOI":"10.1161\/circheartfailure.118.005220","volume":"11","author":"JAJ Verdonschot","year":"2018","unstructured":"Verdonschot, J. A. J. et al. Clinical phenotype and genotype associations with improvement in left ventricular function in dilated cardiomyopathy. Circ. Heart Fail. 11, e005220. https:\/\/doi.org\/10.1161\/circheartfailure.118.005220 (2018).","journal-title":"Circ. Heart Fail."},{"key":"8495_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/gb-2011-12-5-222","volume":"12","author":"TA Dittmer","year":"2011","unstructured":"Dittmer, T. A. & Misteli, T. The lamin protein family. Genome Biol. 12, 222. https:\/\/doi.org\/10.1186\/gb-2011-12-5-222 (2011).","journal-title":"Genome Biol."},{"key":"8495_CR8","doi-asserted-by":"publisher","unstructured":"Lazarte, J. & Hegele, R. A.  Lamin A\/C missense variants: from discovery to functional validation. Npj Genomic Med. 6, 102. https:\/\/doi.org\/10.1038\/s41525-021-00266-w (2021).","DOI":"10.1038\/s41525-021-00266-w"},{"key":"8495_CR9","doi-asserted-by":"publisher","unstructured":"Peng, Y., Tang, Q., Xiao, F. & Fu, N. Regulation of lipid metabolism by lamin in mutation-related diseases. Front. Pharmacol. 13, 563.  https:\/\/doi.org\/10.3389\/fphar.2022.820857 (2022).","DOI":"10.3389\/fphar.2022.820857"},{"key":"8495_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-pathol-042220-034240","volume":"17","author":"JY Shin","year":"2022","unstructured":"Shin, J. Y. & Worman, H. J. Molecular pathology of laminopathies. Annu. Rev. Pathol. 17, 159\u2013180. https:\/\/doi.org\/10.1146\/annurev-pathol-042220-034240 (2022).","journal-title":"Annu. Rev. Pathol."},{"key":"8495_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11897-023-00589-y","volume":"20","author":"SM Ng","year":"2023","unstructured":"Ng, S. M., Neubauer, S. & Rider, O. J. Myocardial metabolism in heart failure. Curr. Heart Fail. Rep. 20, 63\u201375. https:\/\/doi.org\/10.1007\/s11897-023-00589-y (2023).","journal-title":"Curr. Heart Fail. Rep."},{"key":"8495_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","volume":"113","author":"T Doenst","year":"2013","unstructured":"Doenst, T., Nguyen, T. D. & Abel, E. D. Cardiac metabolism in heart failure. Circul. Res. 113, 709\u2013724. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300376 (2013).","journal-title":"Circul. Res."},{"key":"8495_CR13","doi-asserted-by":"publisher","unstructured":"Bae, J., Paltzer, W. G. & Mahmoud, A. I. The role of metabolism in heart failure and regeneration. Front. Cardiovasc. Med. 8, 1452.  https:\/\/doi.org\/10.3389\/fcvm.2021.702920 (2021).","DOI":"10.3389\/fcvm.2021.702920"},{"key":"8495_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/hmg\/ddi017","volume":"14","author":"T Arimura","year":"2004","unstructured":"Arimura, T. et al. Mouse model carrying H222P- Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum. Mol. Genet. 14, 155\u2013169. https:\/\/doi.org\/10.1093\/hmg\/ddi017 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"8495_CR15","doi-asserted-by":"crossref","unstructured":"West, J. A. et al. A targeted metabolomics assay for cardiac metabolism and demonstration using a mouse model of dilated cardiomyopathy. Metabolomics 12, 2563 (2016).","DOI":"10.1007\/s11306-016-0956-2"},{"key":"8495_CR16","doi-asserted-by":"publisher","unstructured":"Zuela-Sopilniak, N., Morival, J. & Lammerding, J. Multi-level transcriptomic analysis of LMNA-related dilated cardiomyopathy identifies disease-driving processes. bioRxiv 2024, 2024.2006.2011.598511.  https:\/\/doi.org\/10.1101\/2024.06.11.598511  (2024).","DOI":"10.1101\/2024.06.11.598511"},{"key":"8495_CR17","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.nmd.2010.07.013","volume":"20","author":"AT Bertrand","year":"2010","unstructured":"Bertrand, A. T. et al. O.4 mouse model of LMNA-congenital muscular dystrophy shows severe skeletal and cardiac muscle maturation defects associated with major metabolic defects leading to early death. Neuromuscul. Disord. 20, 598. https:\/\/doi.org\/10.1016\/j.nmd.2010.07.013 (2010).","journal-title":"Neuromuscul. Disord."},{"key":"8495_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.atherosclerosis.2023.06.602","volume":"379","author":"F Bonet","year":"2023","unstructured":"Bonet, F. et al. Transcriptome analysis of MiRNA and mRNA in the myocardial tissue of mice with LMNA-dilated cardiomyopathy. Atherosclerosis 379, 179\u2013S180. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.06.602 (2023).","journal-title":"Atherosclerosis"},{"key":"8495_CR19","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1038\/s41598-020-63563-x","volume":"10","author":"Z Shao","year":"2020","unstructured":"Shao, Z. et al. RNA sequence analyses throughout the course of mouse cardiac laminopathy identify differentially expressed genes for cell cycle control and mitochondrial function. Sci. Rep. 10, 6632. https:\/\/doi.org\/10.1038\/s41598-020-63563-x (2020).","journal-title":"Sci. Rep."},{"key":"8495_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41431-018-0294-0","volume":"27","author":"FHJ van Tienen","year":"2019","unstructured":"van Tienen, F. H. J. et al. Assessment of fibroblast nuclear morphology aids interpretation of LMNA variants. Eur. J. Hum. Genet. 27, 389\u2013399. https:\/\/doi.org\/10.1038\/s41431-018-0294-0 (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"8495_CR21","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s42003-023-05627-y","volume":"6","author":"JL Han","year":"2023","unstructured":"Han, J. L., Heinson, Y. W., Chua, C. J., Liu, W. & Entcheva, E. CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes. Commun. Biol. 6, 1236. https:\/\/doi.org\/10.1038\/s42003-023-05627-y (2023).","journal-title":"Commun. Biol."},{"key":"8495_CR22","doi-asserted-by":"publisher","unstructured":"Nijak, A. et al. iPSC-cardiomyocyte models of Brugada syndrome-achievements, challenges and future perspectives. Int. J. Mol. Sci. 22, 145.  https:\/\/doi.org\/10.3390\/ijms22062825 (2021).","DOI":"10.3390\/ijms22062825"},{"key":"8495_CR23","doi-asserted-by":"publisher","unstructured":"Hoorntje, E. T. et al. Lamin A\/C-related cardiac disease: late onset with a variable and mild phenotype in a large cohort of patients with the lamin A\/C p.(Arg331Gln) founder mutation. Circ. Cardiovasc. Genet. 10, 230. https:\/\/doi.org\/10.1161\/circgenetics.116.001631 (2017).","DOI":"10.1161\/circgenetics.116.001631"},{"key":"8495_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/circulationaha.118.039410","volume":"140","author":"K Wahbi","year":"2019","unstructured":"Wahbi, K. et al. Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies. Circulation 140, 293\u2013302. https:\/\/doi.org\/10.1161\/circulationaha.118.039410 (2019).","journal-title":"Circulation"},{"key":"8495_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1006\/jsbi.1998.3987","volume":"122","author":"N Stuurman","year":"1998","unstructured":"Stuurman, N., Heins, S. & Aebi, U. Nuclear lamins: their structure, assembly, and interactions. J. Struct. Biol. 122, 42\u201366. https:\/\/doi.org\/10.1006\/jsbi.1998.3987 (1998).","journal-title":"J. Struct. Biol."},{"key":"8495_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1634\/stemcells.2004-0159","volume":"24","author":"D Constantinescu","year":"2006","unstructured":"Constantinescu, D., Gray, H. L., Sammak, P. J., Schatten, G. P. & Csoka, A. B. Lamin A\/C expression is a marker of mouse and human embryonic stem cell differentiation. Stem Cells. 24, 177\u2013185. https:\/\/doi.org\/10.1634\/stemcells.2004-0159 (2006).","journal-title":"Stem Cells"},{"key":"8495_CR27","doi-asserted-by":"publisher","first-page":"e15336","DOI":"10.1371\/journal.pone.0015336","volume":"6","author":"B Zhang","year":"2011","unstructured":"Zhang, B. et al. Estimating the quality of reprogrammed cells using ES cell differentiation expression patterns. PLoS One. 6, e15336. https:\/\/doi.org\/10.1371\/journal.pone.0015336 (2011).","journal-title":"PLoS One"},{"key":"8495_CR28","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1242\/bio.20121586","volume":"1","author":"B Zuo","year":"2012","unstructured":"Zuo, B. et al. Influences of lamin A levels on induction of pluripotent stem cells. Biol. Open. 1, 1118\u20131127. https:\/\/doi.org\/10.1242\/bio.20121586 (2012).","journal-title":"Biol. Open."},{"key":"8495_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fcell.2018.00172","volume":"6","author":"S Crasto","year":"2018","unstructured":"Crasto, S. & Di Pasquale, E. Induced pluripotent stem cells to study mechanisms of laminopathies: focus on epigenetics. Front. Cell. Dev. Biol. 6, 172. https:\/\/doi.org\/10.3389\/fcell.2018.00172 (2018).","journal-title":"Front. Cell. Dev. Biol."},{"key":"8495_CR30","doi-asserted-by":"publisher","unstructured":"Hoorntje, E. T. et al. \u2009Lamin A\/C-related cardiac disease. Circul. Cardiovasc. Genet. 10, e001631.  https:\/\/doi.org\/10.1161\/CIRCGENETICS.116.001631 (2017).","DOI":"10.1161\/CIRCGENETICS.116.001631"},{"key":"8495_CR31","doi-asserted-by":"publisher","unstructured":"Stiekema, M., van Zandvoort, M., Ramaekers, F. C. S. & Broers, J. L. V. Structural and mechanical aberrations of the nuclear lamina in disease. Cells 9, 145. https:\/\/doi.org\/10.3390\/cells9081884 (2020).","DOI":"10.3390\/cells9081884"},{"key":"8495_CR32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.yexcr.2004.11.020","volume":"304","author":"JL Broers","year":"2005","unstructured":"Broers, J. L. et al. Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization. Exp. Cell. Res. 304, 582\u2013592. https:\/\/doi.org\/10.1016\/j.yexcr.2004.11.020 (2005).","journal-title":"Exp. Cell. Res."},{"key":"8495_CR33","doi-asserted-by":"publisher","unstructured":"Hah, J. & Kim, D. H. Deciphering nuclear mechanobiology in laminopathy. Cells 8, 968. https:\/\/doi.org\/10.3390\/cells8030231 (2019).","DOI":"10.3390\/cells8030231"},{"key":"8495_CR34","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4161\/nucl.21674","volume":"3","author":"A Barascu","year":"2012","unstructured":"Barascu, A. et al. Oxydative stress alters nuclear shape through lamins dysregulation: a route to senescence. Nucleus 3, 411\u2013417. https:\/\/doi.org\/10.4161\/nucl.21674 (2012).","journal-title":"Nucleus"},{"key":"8495_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/j.1582-4934.2009.00690.x","volume":"13","author":"V Verstraeten","year":"2009","unstructured":"Verstraeten, V. et al. The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress. J. Cell. Mol. Med. 13, 959\u2013971. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00690.x (2009).","journal-title":"J. Cell. Mol. Med."},{"key":"8495_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.freeradbiomed.2021.02.041","volume":"166","author":"A Vujic","year":"2021","unstructured":"Vujic, A., Koo, A. N. M., Prag, H. A. & Krieg, T. Mitochondrial redox and TCA cycle metabolite signaling in the heart. Free Radic. Biol. Med. 166, 287\u2013296. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.02.041 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"8495_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2021.02.043","volume":"167","author":"D Bou-Teen","year":"2021","unstructured":"Bou-Teen, D. et al. Mitochondrial ROS and mitochondria-targeted antioxidants in the aged heart. Free Radic. Biol. Med. 167, 109\u2013124. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.02.043 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"8495_CR38","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/hmg\/ddac264","volume":"32","author":"JI de las Heras","year":"2023","unstructured":"de las Heras, J. I. et al. Metabolic, fibrotic and splicing pathways are all altered in Emery-Dreifuss muscular dystrophy spectrum patients to differing degrees. Hum. Mol. Genet. 32, 1010\u20131031. https:\/\/doi.org\/10.1093\/hmg\/ddac264 (2023).","journal-title":"Hum. Mol. Genet."},{"key":"8495_CR39","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1111\/jcmm.17532","volume":"26","author":"Z Du","year":"2022","unstructured":"Du, Z. et al. A novel mutation in human EMD gene and mitochondrial dysfunction in Emerin knockdown cardiomyocytes. J. Cell. Mol. Med. 26, 5054\u20135066. https:\/\/doi.org\/10.1111\/jcmm.17532 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"8495_CR40","doi-asserted-by":"publisher","first-page":"9948","DOI":"10.1093\/nar\/gkac741","volume":"50","author":"S Maynard","year":"2022","unstructured":"Maynard, S. et al. Lamin A\/C impairments cause mitochondrial dysfunction by attenuating PGC1\u03b1 and the NAMPT-NAD\u2009+\u2009pathway. Nucleic Acids Res. 50, 9948\u20139965. https:\/\/doi.org\/10.1093\/nar\/gkac741 (2022).","journal-title":"Nucleic Acids Res."},{"key":"8495_CR41","doi-asserted-by":"publisher","first-page":"7000","DOI":"10.1038\/s41467-024-51318-5","volume":"15","author":"H Qiu","year":"2024","unstructured":"Qiu, H. et al. Lamin A\/C deficiency-mediated ROS elevation contributes to pathogenic phenotypes of dilated cardiomyopathy in iPSC model. Nat. Commun. 15, 7000. https:\/\/doi.org\/10.1038\/s41467-024-51318-5 (2024).","journal-title":"Nat. Commun."},{"key":"8495_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/8904_2011_118","volume":"6","author":"SL Austin","year":"2012","unstructured":"Austin, S. L. et al. Cardiac pathology in glycogen storage disease type III. JIMD Rep. 6, 65\u201372. https:\/\/doi.org\/10.1007\/8904_2011_118 (2012).","journal-title":"JIMD Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08495-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08495-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08495-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T01:02:12Z","timestamp":1751590932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08495-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8495"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08495-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23842"}}